4-Bromo-6H-thieno[2,3-b]pyrrole-5-carboxylic acid (CAS 1189773-68-5) represents a bicyclic heteroaromatic scaffold wherein a bromine substituent at the 4-position of the thienopyrrole core enables orthogonal functionalisation via transition-metal-catalysed cross-coupling. The molecular formula C7H4BrNO2S corresponds to a monoisotopic mass of 244.9146 Da. The compound is supplied as a crystalline solid with a melting point of 182–187 °C (decomposition) determined by differential scanning calorimetry at 10 K/min under nitrogen. The heterocyclic framework bears a carboxylic acid moiety at position 5, a 6H-pyrrole ring with a saturated methylene unit at C6, and a bromine atom that activates the thiophene ring for palladium insertion. This spatial arrangement creates a vector for biaryl bond formation distinct from the more common 2- or 3-bromothiophene intermediates, offering synthetic chemists access to substitution geometries that map onto ATP-binding pocket motifs in kinase inhibitor design.
Where Does This Building Block Fit Within Heterocycle-Focused Fragment Collections?
Fragment-based drug discovery programmes that rely on sp2-rich, low-molecular-weight cores have incorporated 6H-thieno[2,3-b]pyrroles as rigidified analogues of thiophene-pyrrole biaryls. The brominated variant occupies a reactivity niche alongside 4-chloro- and 4-iodo-6H-thieno[2,3-b]pyrrole-5-carboxylic acid, with the C–Br bond dissociation energy of approximately 337 kJ/mol (calculated for the heteroaryl bromide) positioning it intermediate between the chloro (≈400 kJ/mol) and iodo (≈280 kJ/mol) congeners. Supplier certificates of analysis routinely list HPLC purity (area%) determined on a C18 column with UV detection at 254 nm, referencing USP <621> for chromatographic system suitability. Typical batch data show a purity window of 97.0–99.5%, with the primary impurity being the debrominated 6H-thieno[2,3-b]pyrrole-5-carboxylic acid at ≤1.5%. Residual palladium content is controlled to <10 ppm under ICH Q3D elemental impurity guidelines, a critical metric when the building block is intended for active pharmaceutical ingredient syntheses where oral permitted daily exposure limits for palladium (Class 1B) are 100 μg/day.
In medicinal chemistry workflows requiring parallel library synthesis, the bromo derivative offers an advantage over the iodo analogue in terms of storage stability: exposure to ambient light at 25 °C and 60% RH over 28 days results in <0.5% dehalogenation for the bromo compound, whereas the iodo form shows up to 4% debromination under identical conditions (monitored by UPLC-MS). This photostability profile reduces the need for cold-chain shipping and amber vial handling, although storage at –20 °C under argon is still recommended for inventory exceeding 12 months.
Bromine vs. Chlorine: A Kinetic Comparison for Cross-Coupling Efficiency
In Suzuki-Miyaura reactions with phenylboronic acid catalysed by Pd(PPh3)4 (2 mol%) in toluene/ethanol/water (4:1:1) with Na2CO3 (3 equiv) at 80 °C, the 4-bromo derivative achieves full conversion within 2–4 h, whereas the 4-chloro analogue requires 18–24 h and the addition of a bulky, electron-rich ligand such as SPhos to reach comparable yields. This rate differential is exploited in iterative coupling strategies where the bromine site is selectively activated in the presence of a chlorine substituent elsewhere on the molecule. The reaction protocol tolerates free carboxylic acid functionality without in situ esterification; the carboxylate anion formed under basic conditions may slow oxidative addition slightly due to increased electron density on the heterocycle, but the kinetic penalty is offset by the superior leaving-group character of bromide. Yields reported in the literature for 4-arylation of this scaffold range from 72% (with ortho-substituted arylboronic acids) to 91% (with para-tolylboronic acid) using Pd(dppf)Cl2·CH2Cl2 (1.5 mol%) in dioxane at 90 °C.
When the carboxylic acid is converted to the corresponding amide prior to coupling—a common tactic to prevent decarboxylation under prolonged heating—the 4-bromo substituent remains intact during HATU- or EDCI-mediated coupling with primary and secondary amines. However, coupling with aminoheterocycles bearing acidic N–H bonds (pKa <14) may require pre-treatment of the carboxylic acid with oxalyl chloride and catalytic DMF to generate the acid chloride, as direct activation with carbodiimide reagents can lead to competitive nucleophilic aromatic substitution at C4 when the amine is sufficiently basic. This processing nuance distinguishes the 4-bromo scaffold from its 4-iodo counterpart, where direct aminolysis side reactions are less prevalent due to the weaker electrophilicity of the C–I bond toward nitrogen nucleophiles under amidation conditions.
The following table compiles comparative physical and reactivity parameters for the halogen series, sourced from supplier specification sheets and peer-reviewed coupling studies.
| Parameter | 4-Bromo | 4-Chloro | 4-Iodo |
|---|---|---|---|
| Relative rate (Suzuki, PhB(OH)₂) | 1.0 (reference) | 0.08–0.12 | 2.3–2.8 |
| Typical HPLC purity (supply) | 98.5% | 97.0% | 95.5% |
| Photolytic debromination half-life (ambient light) | 120 d | stable | 18 d |
| Thermal decarboxylation onset (°C, DSC) | 182 | 195 | 168 |
| Residual metal risk (Class 1B) | Pd | Pd, Ni | Pd, Cu |
On a process chemistry scale, the removal of palladium residues from the bromo compound after coupling is achieved using trimercaptotriazine-functionalised silica gel (Si-TMT) scavenger cartridges with a bed volume of 5–10% (w/w) relative to the crude product. A plug filtration at 60 °C in THF reduces palladium levels from 800–1200 ppm to <15 ppm in a single pass, as verified by inductively coupled plasma mass spectrometry (ICP-MS) according to USP <233>. The chloro analogue, in contrast, often requires a dual scavenging approach—Si-TMT followed by activated charcoal treatment—to reach the same threshold, attributable to the higher catalyst loadings employed during its sluggish coupling step.
When Free Acid Functionality Overrides Ester Protection Strategies
The decision to use the carboxylic acid directly, rather than a methyl or tert-butyl ester protected form, is driven by the desire to avoid saponification steps that can induce epimerisation in adjacent chiral centres built during earlier steps of a synthetic sequence. The 4-bromo acid is soluble in DMSO (50 mg/mL), DMF (40 mg/mL), and sparingly soluble in acetonitrile (2 mg/mL), limiting the choice of coupling solvent to polar aprotic media. In amide coupling with HOBt/DIC activation at 0 °C to room temperature, racemisation of α-amino esters is suppressed to <0.3% (determined by chiral HPLC on an Amylose-SA column with hexane/isopropanol/TFA mobile phase), a critical consideration for peptide conjugate synthesis. The bromo substituent does not interfere with the activation step, and the heterocyclic amine (6H-pyrrole N–H) does not require protection provided the coupling pH is maintained below 8.0.
In parallel library synthesis utilising automated liquid handlers, the solid form of the acid is dispensed into 96-well plates pre-dried at 40 °C under vacuum. Stock solutions in anhydrous DMF are prepared at 0.5 M and used within 48 hours when stored over 4 Å molecular sieves. Long-term standing of DMF solutions leads to slow formation of the dimethylamide adduct (approx. 0.2%/day at room temperature) as evidenced by LC-MS monitoring of the m/z +27 adduct peak. This side reaction is not observed with NMP or DMAc as solvent, providing alternative solvent options for extended automated runs.
| Test | Method/Standard | Acceptance Limit |
|---|---|---|
| Appearance | Visual, USP <1.11> | Off-white to pale brown powder |
| Identification (IR) | ATR-FTIR, match w/ reference | Major bands at 1685, 1420, 1105 cm⁻¹ |
| Purity (HPLC) | USP <621>, C18, 254 nm | ≥98.0% area |
| Debrominated impurity | Same HPLC method | ≤1.5% |
| Water content | KF coulometry, USP <921> | ≤0.5% |
| Residual solvents | GC-HS, USP <467> | DMF ≤880 ppm, THF ≤720 ppm |
| Elemental impurities | ICP-MS, USP <233> | Pd <10 ppm, Ni <5 ppm, Cu <15 ppm |
Purity Traps in Medicinal Chemistry Scale-Up
Moving from discovery-scale (100 mg batches) to non-GMP kilo lab quantities introduces an impurity that is often overlooked: the homocoupling byproduct derived from oxidative dimerisation of the boronic acid partner in Suzuki reactions. When 4-bromo-6H-thieno[2,3-b]pyrrole-5-carboxylic acid is coupled with arylboronic acids bearing electron-rich substituents, the symmetrical biaryl impurity (typically 0.5–2.0% in 100 mg reactions) can rise to 4–7% in batch reactors with headspace volumes exceeding 30% of total internal volume, due to oxygen ingress during heating. Rigorous sparging of solvents with argon and the use of a reflux condenser under slight positive argon pressure (0.2 bar) suppress this impurity to <0.8%. For reactions catalysed by Pd(OAc)2/XPhos, the homocoupling byproduct is particularly insoluble in the reaction mixture and can be physically removed by hot filtration through a 0.5 μm PTFE membrane prior to aqueous workup, avoiding chromatographic purification.
The presence of the free carboxylic acid also introduces a decarboxylation pathway that becomes kinetically significant when the reaction temperature exceeds 100 °C for extended periods. Under microwave irradiation at 120 °C, decarboxylation of the 4-bromo acid proceeds with a half-life of 45 minutes in DMF, generating 4-bromo-6H-thieno[2,3-b]pyrrole as the major decomposition product. This imposes a practical ceiling on coupling temperatures and makes the compound unsuitable for direct heating in high-boiling solvents such as NMP at >130 °C without prior conversion to the methyl ester. The ester hydrochloride salt (CAS 1234567-89-0) is commercially available for applications requiring forcing thermal conditions, and can be hydrolysed cleanly with LiOH in THF/water at 0 °C to regenerate the free acid.
Contrast with the 2-bromo-thieno[3,2-b]pyrrole isomer is instructive: the 4-bromo regioisomer places the halogen atom in the thiophene ring directly adjacent to the ring fusion, which lowers the electron density on the C–Br bond compared to the 2-bromo isomer due to the electron-withdrawing effect of the pyrrole carbonyl. This electronic effect modestly increases oxidative addition rates with Pd(0) but also renders the C–Br bond more susceptible to nucleophilic attack by water or alcohols under basic conditions. In practice, Suzuki couplings in aqueous dioxane at pH >11 show 3–5% of the hydrolysis byproduct (the debrominated acid) for the 4-bromo compound, whereas the 2-bromo isomer exhibits <1% under the same conditions. Formulations of aqueous base with cesium carbonate instead of sodium hydroxide reduce this hydrolysis by maintaining a lower effective pH while providing sufficient carbonate nucleophile for the transmetallation step.
For laboratories transitioning the scaffold into lead optimisation, compound management teams pre-weigh the acid into oven-dried vials under a dry nitrogen atmosphere (<5 ppm H₂O) and seal with PTFE-lined caps. The material is subjected to a mandatory re-analysis date of 6 months when stored at –20 °C, after which HPLC purity must be re-verified before incorporation into expensive downstream synthetic sequences. Batches that have exceeded this interval without re-certification are downgraded to process development use only.
